Damora Therapeutics
DMRA
#5408
Rank
A$2.17 B
Marketcap
A$35.08
Share price
-4.44%
Change (1 day)
35.10%
Change (1 year)

Earnings for Damora Therapeutics (DMRA)

Earnings in 2026 (TTM): -A$0.44 Billion

According to Damora Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$0.32 Billion a decrease over its 2024 earnings that were of -A$32.33 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Damora Therapeutics from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.44 Billion35.83%
2025 -A$0.32 Billion880.41%
2024 -A$32.33 Million-44.2%
2023 -A$57.94 Million-37.77%
2022 -A$93.11 Million19.08%
2021 -A$78.19 Million48.55%
2020 -A$52.64 Million